Skip to content
10-Q

Quarterly Report

BIOCEPT, INC.

0000950170-23-042468

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 8, 2023 2.63M sh
Shares Diluted Q2 2023 · Jun 30, 2023 1.04M sh
Shares Diluted Q2 2023 · Jun 30, 2023 813.18K sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 563.53K sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 562.56K sh
Capex Q2 2023 · Jun 30, 2023 $188K
Capex Q2 2023 · Jun 30, 2022 $315K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$9.28M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$4.97M
Stockholders Equity Q2 2023 · Jun 30, 2023 $290K
Stockholders Equity Q2 2023 · Mar 31, 2023 $2.43M
Stockholders Equity Q2 2023 · Dec 31, 2022 $8.86M
Stockholders Equity restated Q2 2023 · Jun 30, 2022 $27.66M
Stockholders Equity Q2 2023 · Mar 31, 2022 $37.03M
Stockholders Equity Q2 2023 · Dec 31, 2021 $37.48M
Current Liabilities Q2 2023 · Jun 30, 2023 $4.9M
Current Liabilities Q2 2023 · Dec 31, 2022 $5.51M
Total Liabilities Q2 2023 · Jun 30, 2023 $21.81M
Total Liabilities Q2 2023 · Dec 31, 2022 $22.01M
Current Assets Q2 2023 · Jun 30, 2023 $8.86M
Current Assets Q2 2023 · Dec 31, 2022 $16.34M
Total Assets Q2 2023 · Jun 30, 2023 $22.1M
Total Assets Q2 2023 · Dec 31, 2022 $30.87M
Eps Diluted Q2 2023 · Jun 30, 2023 −$3.50
Eps Diluted Q2 2023 · Jun 30, 2023 −$13.25
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$17.82
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$21.78
Eps Basic Q2 2023 · Jun 30, 2023 −$3.50
Eps Basic Q2 2023 · Jun 30, 2023 −$13.25
Eps Basic restated Q2 2023 · Jun 30, 2022 −$17.82
Eps Basic restated Q2 2023 · Jun 30, 2022 −$21.78
Sga Expense Q2 2023 · Jun 30, 2023 $3.49M
Sga Expense Q2 2023 · Jun 30, 2023 $6.48M
Sga Expense Q2 2023 · Jun 30, 2022 $4.3M
Sga Expense restated Q2 2023 · Jun 30, 2022 $10.56M
Rd Expense Q2 2023 · Jun 30, 2023 $409K
Rd Expense Q2 2023 · Jun 30, 2023 $1.45M
Rd Expense Q2 2023 · Jun 30, 2022 $1.73M
Rd Expense restated Q2 2023 · Jun 30, 2022 $3.57M
Net Income Q2 2023 · Jun 30, 2023 −$3.63M
Net Income Q2 2023 · Jun 30, 2023 −$10.78M
Net Income Q2 2023 · Mar 31, 2023 −$7.14M
Net Income restated Q2 2023 · Jun 30, 2022 −$10.04M
Net Income restated Q2 2023 · Jun 30, 2022 −$12.26M
Net Income restated Q2 2023 · Mar 31, 2022 −$2.21M
Operating Income Q2 2023 · Jun 30, 2023 −$6.11M
Operating Income Q2 2023 · Jun 30, 2023 −$13.21M
Operating Income restated Q2 2023 · Jun 30, 2022 −$9.89M
Operating Income restated Q2 2023 · Jun 30, 2022 −$12.04M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $2.55M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $5.58M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $8.02M
Cost Of Revenue restated Q2 2023 · Jun 30, 2022 $18.36M
Revenue Q2 2023 · Jun 30, 2023 $589K
Revenue Q2 2023 · Jun 30, 2023 $1.26M
Revenue restated Q2 2023 · Jun 30, 2022 $5.82M
Revenue restated Q2 2023 · Jun 30, 2022 $25.76M